NSE - SMEListed
Mono Pharmacare Limited
Company websiteThe company Mono Pharmacare Limited has filed papers to raise ₹53,00,000 crore through a public issue. The offering includes a fresh tranche of ₹53,00,000 crore and OFS of ₹0 crore.
Investors may apply between 28-08-2023 and 30-08-2023. Expected allotment is on 04-09-2023 and listing is aimed for 07-09-2023. This is a standard structure — fresh capital for growth, OFS for seller liquidity.
Start Date28-08-2023
End Date30-08-2023
Listing Date07-09-2023
Allotment Date04-09-2023
Current Price₹29
GMP₹2 (7.14%)
Lot Size4000 Shares
Subscription13.47 Times
Face Value₹10 per share
Listing atNSE
Issue Price₹26 - ₹28
Pre Issue₹1,23,68,564
Post Issue₹1,76,68,564
Issue Size₹53,00,000
(aggregating up to 14.84 Cr)
(aggregating up to 14.84 Cr)
Fresh Issue₹53,00,000
(aggregating up to 14.84 Cr)
(aggregating up to 14.84 Cr)
Offer For Sale-
The Grey Market Premium (GMP) for Mono Pharmacare Limited is currently around ₹2 (7.14%). This indicates an estimated listing price of approximately ₹28 based on the latest market sentiment. Please note that GMP values are unofficial and can change frequently as they depend on demand, market conditions, and investor activity.
Gmp Details
| Last Updated | IPO Price | GMP | Estimated Listing Price |
|---|---|---|---|
07 Nov 2025, 08:54 | ₹28 | ₹2 | ₹30 (7.14%) |
04 Apr 2025, 09:24 | ₹28 | ₹2 | ₹30 (7.14%) |
19 Mar 2025, 12:17 | ₹28 | ₹2 | ₹30 (7.14%) |
Financials overview in Lakhs
Here is a quick look at the recent financial performance of Mono Pharmacare Limited . The numbers below ( in Lakhs ) show how the company’s revenue and profits have changed over the last few years. This helps investors understand how strongly the business is growing and how stable its financial health is before applying for the IPO.
Key Performance
| KPI | Values |
|---|---|
EPS | 1.99 |
ROE | 9.01 |
ROCE | 10.34 |
RONW | 9.01 |
PRE IPO(PE) | 0 |
POST IPO(PE) | 40 |
Subscription Demand (in ₹ Crore)
| Category | Offered | Demand | Times |
|---|---|---|---|
QIBs | ₹1.40 | 15.24 | 10.89 |
RETAIL | ₹6.34 | 122.89 | 19.38 |
Total | ₹7.74 | 138.13 | 17.85 |
The IPO reservation for Mono Pharmacare Limited shows how the total issue is divided among different investor categories. This includes allocations for Retail Investors, Qualified Institutional Buyers (QIBs), and Non-Institutional Investors (NIIs). Understanding the reservation structure helps investors know how much of the issue is set aside for their category before applying.
IPO Reservation
| Category | Shares Offers | No. of Shares |
|---|---|---|
Retail | 42.72% | 22,64,000 |
NII(HNI) | 42.64% | 22,60,000 |
QIB | 9.43% | 5,00,000 |
Market Maker | 5.21% | 2,76,000 |
TOTAL | 100.00% | 53,00,000 |
Lot(s) Distribution
| Category | Lot(s) | Qty | Amount | Reserved |
|---|---|---|---|---|
Retail (Min) | 1 | 4,000 | ₹1,12,000 | |
HNI | 2 | 8,000 | ₹2,24,000 |
Below you can find the official contact details of Mono Pharmacare Limited along with the registrar handling the IPO process. This information helps investors reach out for queries related to the company or for checking the allotment status and application updates once the IPO process begins.
Company Details
Email: cs@monopharmacareltd.com
Phone: +91 99780 41356
Website: https://monopharmacareltd.com/
Address: 1A, Krinkal Apartment Opp. Mahalaxmi Temple, Paldi Ahmedabad -380007